Commercial health plan initiation of a co-pay accumulator adjustment program for specialty medications treating autoimmune diseases was associated with significant reductions in medication adherence and persistence.
Andrew J. Epstein, PhD
Advertisement
Articles by Andrew J. Epstein, PhD
Federal parity led to an increase in spending on substance use disorder treatment.
Advertisement
Latest Updated Articles
- Impact of a Co-pay Accumulator Adjustment Program on Specialty Drug Adherence
Published: July 17th 2019 | Updated:
- The Effects of Federal Parity on Substance Use Disorder Treatment
Published: January 23rd 2014 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
New Partnership Model Boosts Maternal Outcomes in Medicaid ACOs
2
Value-Based Care Interventions and Management of CKD Progression
3
Better Food, Better Health: Redefining Chronic Disease Care Through Nutrition
4
CAR T-Cell Therapy Holds Potential in SCLC, but Significant Barriers Remain
5
